TW200816995A - Pharmaceutical composition containing insulin sensitizers - Google Patents

Pharmaceutical composition containing insulin sensitizers

Info

Publication number
TW200816995A
TW200816995A TW96132174A TW96132174A TW200816995A TW 200816995 A TW200816995 A TW 200816995A TW 96132174 A TW96132174 A TW 96132174A TW 96132174 A TW96132174 A TW 96132174A TW 200816995 A TW200816995 A TW 200816995A
Authority
TW
Taiwan
Prior art keywords
pharmaceutical composition
composition containing
insulin sensitizers
containing insulin
insulin
Prior art date
Application number
TW96132174A
Inventor
Shoichi Kanda
Ryutaro Nakashima
Original Assignee
Daiichi Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to JP2006235021 priority Critical
Application filed by Daiichi Sankyo Co Ltd filed Critical Daiichi Sankyo Co Ltd
Publication of TW200816995A publication Critical patent/TW200816995A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/18Sulfonamides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • A61K31/198Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/4035Isoindoles, e.g. phthalimide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/427Thiazoles not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4453Non condensed piperidines, e.g. piperocaine only substituted in position 1, e.g. propipocaine, diperodon
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/64Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide

Abstract

The present invention provides a therapeutic method for diabetes which can exhibits an excellent hypoglycaemia activity with little side effect. A medicine combining an insulin secretagogue and an insulin sensitizer.
TW96132174A 2006-08-31 2007-08-30 Pharmaceutical composition containing insulin sensitizers TW200816995A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2006235021 2006-08-31

Publications (1)

Publication Number Publication Date
TW200816995A true TW200816995A (en) 2008-04-16

Family

ID=39135950

Family Applications (1)

Application Number Title Priority Date Filing Date
TW96132174A TW200816995A (en) 2006-08-31 2007-08-30 Pharmaceutical composition containing insulin sensitizers

Country Status (2)

Country Link
TW (1) TW200816995A (en)
WO (1) WO2008026668A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009038107A1 (en) * 2007-09-21 2009-03-26 Kissei Pharmaceutical Co., Ltd. Combined pharmaceutical preparation for treatment of type-2 diabetes

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI238064B (en) * 1995-06-20 2005-08-21 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes
US5859037A (en) * 1997-02-19 1999-01-12 Warner-Lambert Company Sulfonylurea-glitazone combinations for diabetes
US6011049A (en) * 1997-02-19 2000-01-04 Warner-Lambert Company Combinations for diabetes
YU37301A (en) * 1998-11-12 2005-06-10 Smithkline Beecham P.L.C. Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent
JP2001039976A (en) * 1999-05-24 2001-02-13 Sankyo Co Ltd Hydrochloride of condensed heterocyclic compound
US20010036479A1 (en) * 2000-01-14 2001-11-01 Gillian Cave Glyburide composition

Also Published As

Publication number Publication date
WO2008026668A1 (en) 2008-03-06

Similar Documents

Publication Publication Date Title
Nierenberg Predictors of response to antidepressants: General principles and clinical implications.
EP1799286B8 (en) Dose display mechanism for a drug delivery device
TW200812591A (en) Polymorphs
AT424881T (en) An implantable medical device with display hardware for movable
MX2009007180A (en) Piperidine gpcr agonists.
CL2011000899A1 (en) aryl compounds, modulators of GPR120 activity in a cell; pharmaceutical composition; and use of such compounds for treating Type I diabetes, ii, metabolic syndrome, stimulate the production of insulin, lowering the level of blood glucose.
WO2007130491A3 (en) Patient customized therapeutic regimens
WO2007124461A3 (en) Glp-1 compounds
HK1152055A1 (en) Hyaluronic acid derivative and drug containing the same
NZ576570A (en) 7-sulfonylamino-2-thiazol and 2-thiadiazol -indole compounds
IL225198A (en) Aminotetrahydropyran compounds, pharmaceutical compositions comprising the same and the use thereof for the treatment of diabetes
MY156306A (en) Use of ultrarapid acting insulin
EP2079500A4 (en) Infusion devices and methods
SI2554183T1 (en) Pharmaceutical composition comprising a GLP-1-agonist, an insulin, and methionine
TW200833387A (en) Improvements in and relating to drive mechanisms suitable for use in drug delivery devices
TW200836787A (en) Improvements in and relating to drive mechanisms suitable for use in drug delivery devices
GEP20115359B (en) Fused cyclic compounds
IL186303A (en) 1h-benzimidazole-4-carboxamides substituted with a quaternary carbon at the 2-position, pharmaceutical compositions comprising same and use thereof for preparation of a medicament for treating cancer
TW200904419A (en) Modulators of pharmacokinetic properties of therapeutics
WO2007107470A3 (en) Pyrazoles as 11-beta-hsd-1
MX2010012292A (en) Gpr119 receptor agonists.
BR112012017054A2 (en) "Oxyntomodulin peptide analog, their use and pharmaceutical composition"
ZA200810532B (en) Projectile for administering a medicament
WO2010008739A3 (en) Aryl gpr119 agonists and uses thereof
WO2008083238A3 (en) Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders